CLINICAL_TRIALS
trial_result
· 2025-10-22
Clinical Trial Update: A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema [Phase 2]
Summary
A Phase 2 trial of the investigational drug Vamikibart (RO7200220) for diabetic macular edema has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED